- Home
- SBFM vs MFC Comparison
SBFM vs MFC Comparison
Compare SBFM & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MFC
- Stock Information
- Founded
- SBFM 2006
- MFC 1887
- Country
- SBFM United States
- MFC Canada
- Employees
- SBFM N/A
- MFC N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MFC Life Insurance
- Sector
- SBFM Health Care
- MFC Finance
- Exchange
- SBFM Nasdaq
- MFC Nasdaq
- Market Cap
- SBFM 6.6M
- MFC 49.3B
- IPO Year
- SBFM N/A
- MFC 1999
- Fundamental
- Price
- SBFM $1.54
- MFC $30.47
- Analyst Decision
- SBFM Strong Buy
- MFC Buy
- Analyst Count
- SBFM 1
- MFC 1
- Target Price
- SBFM $15.00
- MFC $51.00
- AVG Volume (30 Days)
- SBFM 188.9K
- MFC 2.3M
- Earning Date
- SBFM 08-15-2025
- MFC 08-06-2025
- Dividend Yield
- SBFM N/A
- MFC 3.93%
- EPS Growth
- SBFM N/A
- MFC 14.95
- EPS
- SBFM N/A
- MFC 1.85
- Revenue
- SBFM $36,234,578.00
- MFC $20,887,744,800.00
- Revenue This Year
- SBFM $192.48
- MFC $35.15
- Revenue Next Year
- SBFM N/A
- MFC $5.64
- P/E Ratio
- SBFM N/A
- MFC $16.51
- Revenue Growth
- SBFM 35.51
- MFC 9.27
- 52 Week Low
- SBFM $1.17
- MFC $23.30
- 52 Week High
- SBFM $7.18
- MFC $33.07
- Technical
- Relative Strength Index (RSI)
- SBFM 51.91
- MFC 40.45
- Support Level
- SBFM $1.43
- MFC $30.44
- Resistance Level
- SBFM $1.61
- MFC $30.90
- Average True Range (ATR)
- SBFM 0.11
- MFC 0.51
- MACD
- SBFM 0.01
- MFC -0.14
- Stochastic Oscillator
- SBFM 41.67
- MFC 11.46
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About MFC Manulife Financial Corporation
Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.